Zobrazeno 1 - 10
of 213
pro vyhledávání: '"A. Yu. Lebedeva"'
Autor:
A. I. Sapina, A. Yu. Lebedeva, P. P. Savvinova, E. A. Zorina, E. S. Kolosova, E. Yu. Vasilyeva
Publikováno v:
Российский кардиологический журнал, Vol 29, Iss 3 (2024)
Aim. To assess the rate of adverse cardiovascular events (a combination of non-fatal myocardial infarction (MI), non-fatal stroke, cardiovascular death) within 12 months after MI in patients who were followed up in outpatient clinics in Moscow after
Externí odkaz:
https://doaj.org/article/38bdea8692e348ab9f8333a8101e1be6
Publikováno v:
Аграрная наука Евро-Северо-Востока, Vol 24, Iss 3, Pp 487-497 (2023)
An experiment was conducted in the conditions of an industrial complex specializing in the intensive fattening of young cattle, to study the development patterns of respiratory and gastrointestinal pathologies in calves with a history of previous pro
Externí odkaz:
https://doaj.org/article/ea26a265c93b4440beeb95dc2d617c81
Publikováno v:
Российский кардиологический журнал, Vol 28, Iss 7 (2023)
Left ventricular (LV) thrombosis is a common complication of heart failure with reduced LV ejection fraction and can be a source of systemic embolism. The material presents the case of a 76-year-old woman with a history of myocardial infarction, LV a
Externí odkaz:
https://doaj.org/article/03bfc3b98f9e4ac2b71af689b1765ed6
Autor:
A. Yu. Lebedeva, O. M. Koteshkova, O. N. Dzhioeva, S. R. Gilyarevsky, T. M. Uskach, M. S. Novikova, Ya. A. Orlova, V. Yu. Kalashnikov, D. V. Privalov, N. A. Ananicheva, M. Yu. Gilyarov, A. D. Erlikh
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 17, Iss 1, Pp 165-168 (2021)
The results of the international multicenter study EMPEROR-REDUCED were reviewed the on-line scientific meeting of Moscow experts on October 30, 2020. Some proposals and recommendations for further study of the cardiovascular and renal effects of emp
Externí odkaz:
https://doaj.org/article/8642d167fac5420cbea6c65fee3a0b3e
Autor:
Yu. M. Lopatin, G. P. Arutyunov, A. S. Ametov, F. T. Ageev, M. B. Antsiferov, O. L. Barbarash, S. V. Villevalde, N. G. Vinogradova, G. R. Galstyan, A. S. Galyavich, S. R. Gilyarevsky, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, A. Yu. Lebedeva, S. V. Nedogoda, V. V. Salukhov, E. I. Tarlovskaya, S. N. Tereshchenko, I. V. Fomin, Yu. Sh. Khalimov, D. V. Cherkashin
Publikováno v:
Российский кардиологический журнал, Vol 27, Iss 3 (2022)
An online expert meeting held on November 17, 2021 reviewed the results of the randomized, double-blind, multinational, parallel-group EMPULSE trial, evaluating the clinical benefit and safety of the sodium-glucose co-transporter-2 inhibitor (SGLT2i)
Externí odkaz:
https://doaj.org/article/ee648580dd8b4bcaa3917713fdc86a35
Autor:
G. P. Arutyunov, A. G. Arutyunov, E. I. Tarlovskaya, A. S. Ametov, N. G. Vinogradova, A. A. Garganeeva, M. G. Glezer, I. V. Zhirov, M. V. Ilyin, N. A. Koziolova, A. O. Konradi, A. Yu. Lebedeva, Yu. M. Lopatin, S. V. Nedogoda, V. V. Salukhov, M. Yu. Sitnikova, S. N. Tereshchenko, S. N. Tolstov, Yu. Sh. Khalimov, N. R. Khasanov, A. I. Chesnikova, V. Giga, M. Paсker
Publikováno v:
Российский кардиологический журнал, Vol 25, Iss 11 (2020)
At the online meeting held on September 3, 2020, the results of the international multicenter trial EMPEROR-REDUCED were considered. Number of proposals and recommendations for the further study of cardiovascular and renal effects of empagliflozin an
Externí odkaz:
https://doaj.org/article/a3a3f78f9f8848ac8a0840a2dddb6e4c
Autor:
M. V. Zhuravleva, A. Yu. Lebedeva
Publikováno v:
Медицинский совет, Vol 0, Iss 16, Pp 24-31 (2018)
Orphan diseases are life-threatening, chronic, progressive and leading to a reduction in life expectancy or disability conditions. Patients with rare diseases are one of the vulnerable population groups, which is caused by several factors, such as in
Externí odkaz:
https://doaj.org/article/9122dfee785947118f3707827cb3c0d9
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 1, Pp 83-88 (2018)
The review presents recent studies demonstrating somatic shifts in psychological processes regarded as the risk factors for myocardial infarction: depression, stress, anxiety. Based upon a metaphorical term “a perfect storm”, inflammatory, immuno
Externí odkaz:
https://doaj.org/article/a5c5cb6f9ee1419fbc922676bd61e69d
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 2, Pp 90-94 (2016)
The article focuses on the comparative analysis of tactics of the rational complete and incomplete revascularizations in patients with ST elevation myocardial infarction and angina, underwent multivessel stenting and coronary bypass grafting.Patients
Externí odkaz:
https://doaj.org/article/f93173368f5e4fdb98e7847e4566bae6
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 5, Pp 6-11 (2013)
Aim. To assess the association between the changes in heart rate variability (HRV) and hemostatic parameters in patients with coronary heart disease (CHD) and chronic heart failure (CHF) as its complication. Material and methods. In total, 65 patient
Externí odkaz:
https://doaj.org/article/388f4ac2884045b189ff61b64cd71206